Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 23, 2007
Pharmacological chaperones in nephrogenic diabetes insipidus: possibilities for clinical applicationJoris H Robben, Peter M T Deen
Journal of the American Society of Nephrology : JASN|August 2, 2011
Succinate receptors in the kidneyPeter M T Deen, Joris H Robben
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 12, 2009
Effect of the cGMP pathway on AQP2 expression and translocation: potential implications for nephrogenic diabetes insipidusMichelle Boone, Marleen Kortenoeven, Joris H Robben, et al.
American Journal of Physiology. Renal Physiology|July 11, 2006
Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidusJoris H Robben, Nine V A M Knoers, Peter M T Deen
American Journal of Physiology. Cell Physiology|December 15, 2010
Regulation of AQP2 localization by S256 and S261 phosphorylation and ubiquitinationGrazia Tamma, Joris H Robben, Christiane Trimpert, et al.
American Journal of Physiology. Renal Physiology|January 7, 2011
Counteracting vasopressin-mediated water reabsorption by ATP, dopamine, and phorbol esters: mechanisms of actionMichelle Boone, Marleen L A Kortenoeven, Joris H Robben, et al.
Journal of Veterinary Emergency and Critical Care (San Antonio, Tex. : 2001)|September 1, 2020
A novel insertion technique for urinary catheters in female dogs with the use of a guidewireJoris H Robben
Kidney International|September 25, 2009
Localization of the succinate receptor in the distal nephron and its signaling in polarized MDCK cellsJoris H Robben, Robert A Fenton, Sarah L Vargas, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2009
Intracellular activation of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus by nonpeptide agonistsJoris H Robben, Marleen L A Kortenoeven, Mozes Sze, et al.
Pageof 12